Hisun Pharma Gets China Approval for Telmisartan Oral Solution for Cats in 2026
Hisun Pharmaceutical's animal health subsidiary received a MARA approval number for telmisartan oral solution for cats, valid from 8 October 2026 to 7 October 2031. The product treats proteinuria from chronic kidney disease, adding a domestically registered chronic-care option to China's feline veterinary market.
Read more →